Scientists at Rothamsted Research have successfully developed wheat with dramatically reduced levels of asparagine, without ...
CRISPR Cas9 gene therapy explained with DNA scissors, hereditary diseases treatment, and designer babies ethical dilemmas ...
Detailed price information for Editas Medicine (EDIT-Q) from The Globe and Mail including charting and trades.
Two research teams mined genomic data from bacteria to create databases containing thousands of antiviral defence proteins ...
Synthego, a pioneering leader in genome engineering solutions, today announced that the Supreme Court of the United States has denied a petition for a writ of certiorari from Agilent Technologies, Inc ...
Join this webinar to hear from a distinguished panel of translational leaders as they discuss how N-of-1 breakthroughs can be ...
A US patent board last week backed the Broad Institute’s claim to CRISPR use in human and animal cells, not the Nobel winners ...
Crispr Therapeutics AG looks set for 2026 revenue inflection as Casgevy ramps; strong efficacy, undervalued shares, robust ...
Anthropic’s leaked Claude Operon adds a life-sciences workspace in its desktop app, supporting CRISPR design, RNA-seq ...
Detailed price information for Crispr Therapeutics Ag (CRSP-Q) from The Globe and Mail including charting and trades.
CRISPR Therapeutics AG (CRSP) is rated Buy, with a 12-month price target of $64.58, driven by CASGEVY's commercial ramp and a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results